Realbotix Corp (XBOTF) Q4 2024 Earnings Call Highlights: Strategic Expansion into AI and Robotics Amidst Corporate Interest

Realbotix Corp (XBOTF) focuses on AI advancements and potential US exchange uplisting while addressing corporate demand and sales process improvements.

Author's Avatar
Jan 31, 2025
Summary
  • Revenue: Not explicitly mentioned in the transcript.
  • Net Income: Not explicitly mentioned in the transcript.
  • Gross Margin: Not explicitly mentioned in the transcript.
  • Cash Flow: Not explicitly mentioned in the transcript.
  • Expenses: Not explicitly mentioned in the transcript.
  • Same-Store Sales Performance: Not explicitly mentioned in the transcript.
  • Store Locations or Number of Outlets: Not explicitly mentioned in the transcript.
Article's Main Image

Release Date: January 29, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Realbotix Corp (XBOTF, Financial) received significant media attention at CES, with over 4 billion media impressions globally.
  • The company is expanding into AI and robotics, with plans to rebrand and focus more on these areas.
  • Realbotix Corp (XBOTF) is exploring outsourcing non-proprietary parts to scale production efficiently.
  • The latest AI version is in beta testing, with completion expected in the coming months.
  • The company is considering uplisting to a US-based exchange to facilitate easier access for US investors.

Negative Points

  • The financial statements do not fully reflect the value of the company's technology and IP due to accounting rules.
  • The company is currently experiencing high interest primarily from corporate clients, with limited individual consumer interest.
  • Realbotix Corp (XBOTF) faces challenges in perfecting technology before reducing costs for consumer market entry.
  • There is a need to develop a more efficient sales process and potentially hire a professional sales team.
  • The company is cautious about share buybacks and uplisting due to potential regulatory and financial implications.

Q & A Highlights

Q: Can you expand on the pipeline after CES and the types of orders you are expecting?
A: We've received between 75 and 100 inquiries post-CES, primarily from corporations such as schools, pharmaceuticals, and electronic companies. The interest is mainly corporate rather than individual, and we are working to streamline our ordering process. - Andrew Kiguel, CEO

Q: How do you characterize Realbotix? Are you more of a hardware or software company?
A: We see ourselves as both. We focus on creating humanoid robots with realistic skin and open-source hardware compatible with various AI forms. We aim to integrate customized AI for clients, offering solutions for sectors like healthcare and companionship. - Andrew Kiguel, CEO

Q: Do you plan to focus on adapting robots for business use, and when might you enter the consumer market?
A: Currently, our focus is on perfecting technology rather than reducing costs. We aim to eventually lower prices for consumer markets, but for now, our AI-powered busts start at $10,000, with full-bodied robots being more expensive. - Andrew Kiguel, CEO

Q: What is your approach to supporting the stock if it falls, and are you considering a Nasdaq listing?
A: We have set aside funds for share buybacks but have not executed them due to regulatory constraints. We are evaluating a Nasdaq listing to increase accessibility for U.S. investors, though it involves additional costs and considerations. - Andrew Kiguel, CEO

Q: How are you managing sales and customer interactions, and do you have a forecast for the next quarters?
A: Currently, management handles sales inquiries directly. We are developing more efficient processes and hiring for sales roles. We do not provide specific guidance but expect this year to be significantly better than last. - Andrew Kiguel, CEO

For the complete transcript of the earnings call, please refer to the full earnings call transcript.